Pharmacology and Therapeutics
-
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
This article has 7 authors:Reviewed by ScreenIT
-
Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
This article has 6 authors:Reviewed by ScreenIT
-
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
This article has 13 authors:Reviewed by ScreenIT
-
A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
This article has 2 authors:Reviewed by ScreenIT
-
Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs
This article has 7 authors:Reviewed by ScreenIT
-
Review of Current Evidence of Hydroxychloroquine in Pharmacotherapy of COVID-19
This article has 3 authors:Reviewed by ScreenIT
-
Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
This article has 22 authors:Reviewed by ScreenIT
-
A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)
This article has 14 authors:Reviewed by ScreenIT
-
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
This article has 3 authors:Reviewed by ScreenIT
-
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study
This article has 13 authors:Reviewed by ScreenIT